The results of the microarray analyses showed that the mRNA levels of the Wnt/β-catenin signaling target genes involved in metabolism, such as TCF7L2, GLP1, AXIN2, FOSL1, and WISP1, were lower in liver tissues from NASH patients (Fig. 1a, b). The gene discussed is GLP1R; the disease is metabolic dysfunction-associated steatohepatitis.